Table 1.
Patient Demographics and Baseline Characteristics
| Measure | Pregabalin | Placebo |
|---|---|---|
| N=170 | N=164 | |
| Sex, n (%) | ||
| Male | 28 (16.5) | 20 (12.2) |
| Female | 142 (83.5) | 144 (87.8) |
| Age, years | ||
| Mean ± SD | 44.5 ± 11.5 | 43.5 ± 10.6 |
| Range | 20–78 | 18–71 |
| Race, n (%) | ||
| Asian | 170 (100.0) | 164 (100.0) |
| Weight, kg | ||
| Mean ± SD | 59.3 ± 8.7 | 58.5 ± 10.0 |
| Range | 40–85 | 36–90 |
| Duration since FM onset, years | ||
| Mean ± SD | 6.0 ± 7.0 | 5.6 ± 6.4 |
| Median (range) | 3.1 (0.3–30.4) | 3.2 (0.3–32.1) |
| Baseline paina | ||
| Mean ± SD | 6.2 ± 1.4 | 6.2 ± 1.4 |
| Median | 6.2 | 6.0 |
| Baseline sleepb | ||
| Mean ± SD | 5.0 ± 2.2 | 4.8 ± 2.0 |
| Median | 5.4 | 5.0 |
Notes: aScore based on an 11-point NRS from 0 (“no pain”) to 10 (“worst possible pain”). bScore based on an 11-point NRS from 0 (“best possible sleep”) to 10 (“worst possible sleep”).
Abbreviations: FM, fibromyalgia; NRS, numerical rating scale; SD, standard deviation.